Prevalence of anosmia in coronavirus disease 2019-confirmed cases
pan Arab Journal of Rhinology • 2021
Publication Information
Authors
Hossam M Abdelazeem, Amira E Esmail, Alaa M Abdelsamie
Keywords
COVID-19, Anosmia, Corona virus
Journal
pan Arab Journal of Rhinology
Publisher
Not Available
Volume
11
Issue
2
Pages
118-124
publication.type
Local
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Objectives
The current study aims to evaluate the prevalence of anosmia and the factors affecting it in coronavirus disease 2019 (COVID-19)-confirmed cases.
Patients and methods
A cross-sectional, multicenter study was conducted on 400 COVID-19-confirmed patients. The clinical data were collected from patients, either hospitalized in COVID-19 units of different isolation hospitals or home-quarantined, in Egypt. Data were collected through a predesigned survey-based 16 questionnaire, available in two forms, one in a written form and the other was online-designed by Google forms.
Results
The prevalence of anosmia was 68.8% in COVID-19-confirmed cases. About 41.1% of the patients had isolated anosmia. There were no significant differences between those with anosmia and those without as regards smoking and chronic rhinological status, P values were 0.118 and 0.132, respectively.
Conclusion
As a prevalent symptom of COVID-19 patients, anosmia will raise the suspicion index of health staff in developing countries with limited access to the COVID-19 test.
The current study aims to evaluate the prevalence of anosmia and the factors affecting it in coronavirus disease 2019 (COVID-19)-confirmed cases.
Patients and methods
A cross-sectional, multicenter study was conducted on 400 COVID-19-confirmed patients. The clinical data were collected from patients, either hospitalized in COVID-19 units of different isolation hospitals or home-quarantined, in Egypt. Data were collected through a predesigned survey-based 16 questionnaire, available in two forms, one in a written form and the other was online-designed by Google forms.
Results
The prevalence of anosmia was 68.8% in COVID-19-confirmed cases. About 41.1% of the patients had isolated anosmia. There were no significant differences between those with anosmia and those without as regards smoking and chronic rhinological status, P values were 0.118 and 0.132, respectively.
Conclusion
As a prevalent symptom of COVID-19 patients, anosmia will raise the suspicion index of health staff in developing countries with limited access to the COVID-19 test.
Staff Members - Benha University